Results 101 to 110 of about 1,090 (156)

[Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement].

open access: yesEndokrynologia Polska, 2009
Tomasz, Bednarczuk   +28 more
openaire   +1 more source

The role of monoclonal antibodies against IL-6 or IL-6R in the treatment of thyroid eye disease. [PDF]

open access: yesRev Endocr Metab Disord
Ezra DG   +7 more
europepmc   +1 more source

Sarilumab in the management of Graves orbitopathy with low clinical activity scores. [PDF]

open access: yesSci Rep
Pérez-Moreiras J   +3 more
europepmc   +1 more source

A Case Report of a Patient with Thyroid eye disease Induced by Hashimoto's Thyroiditis. [PDF]

open access: yesProbl Endokrinol (Mosk)
Khaskhazyan MH   +4 more
europepmc   +1 more source

Editorial: Thyroid eye disease. [PDF]

open access: yesFront Ophthalmol (Lausanne)
Kahana A   +4 more
europepmc   +1 more source

Targeting IL-6 Receptor Signaling with Satralizumab in Thyroid Eye Disease: Design of the Phase 3 SatraGO-1 and SatraGO-2 Trials. [PDF]

open access: yesOphthalmol Ther
Ezra D   +7 more
europepmc   +1 more source

Thyroid eye disease in paediatric Graves' disease: a case series from the Gulf region with comparison to adults. [PDF]

open access: yesInt Ophthalmol
Aljufairi FMAA   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy